Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
SAN DIEGO, October 8 /PRNewswire/ --
- Company Announces Corporate Restructuring to Focus on Strategic Alliances and M&A
Nventa Biopharmaceuticals Corporation (TSX: NVN), a company developing…